Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference

MONTREAL, QC, April 9, 2026 /PRNewswire/ -- Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein misfolding, including MC4R-deficient (MC4R-d) genetic obesity, GBA1-driven...